Market research
002630.KO ORIENT BIO Inc
KO KRW Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 42B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.0
Profile
Instrument facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- KR7002630002
- Market cap
- 42B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.0
About
About ORIENT BIO Inc
ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic and kits; claim management; serology regents; supply of biological materials used for new drug development process; and mouse, rat, and hamster antibody production testing services. In addition, it engages in automotive and automobile parts production and sales; preclinical and clinical trial agency business; manufacturing, import, and export pharmaceuticals, manufacturing, processing, wholesaling, and retailing of watches; and construction works. It has strategic partnerships with ELLEGARD in the Netherlands and CSIMC in China. It serves research institutions, pharmaceutical companies, and healthcare providers. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is headquartered in Seongnam-si, South Korea.
Research context
ORIENT BIO Inc appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 002630.KO discussion.
5 years, 6 months ago
ORIENT BIO Inc is currently in a long term downtrend where the price is trading 19.9% below its 200 day moving average.
From a valuation standpoint, the stock is 59.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
ORIENT BIO Inc's total revenue rose by 35.1% to $14B since the same quarter in the previous year.
Its net income has increased by 556.6% to $4B since the same quarter in the previous year.
Finally, its free cash flow grew by 126.2% to $803M since the same quarter in the previous year.
Based on the above factors, ORIENT BIO Inc gets an overall score of 4/5.